Sana Biotechnology sells 21.6M shares for $69M in at-the-market offering

Sana Biotechnology, Inc.

Sold 21,607,878 shares for net proceeds of approx. $69.0 million on May 15, 2026.
Equity sale conducted under amended and restated sales agreement with TD Securities as agent.
Offering utilized existing at-the-market facility; no new registration statement filed.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.